
L&M Data Science Ltd is a startup specializing in multi-modal preclinical neuroimaging data services for the pharmaceutical industry, aiming to revolutionize drug discovery by increasing confidence in preclinical data, improving clinical trial success rates, and reducing time-to-market. Their flagship product, neuroPhINDr, is an AI-powered, high-throughput platform that standardizes data acquisition, processing, and analysis of brain imaging modalities such as BOLD MRI, arterial spin labeling, and EEG. The company offers consultancy, data acquisition, data analysis, and development services, leveraging cloud computing and machine learning to deliver rapid, scalable, and comprehensive neuroimaging insights. Based in London, L&M Data Science targets pharmaceutical companies seeking to enhance translational value in CNS drug development and early clinical trial success.

L&M Data Science Ltd is a startup specializing in multi-modal preclinical neuroimaging data services for the pharmaceutical industry, aiming to revolutionize drug discovery by increasing confidence in preclinical data, improving clinical trial success rates, and reducing time-to-market. Their flagship product, neuroPhINDr, is an AI-powered, high-throughput platform that standardizes data acquisition, processing, and analysis of brain imaging modalities such as BOLD MRI, arterial spin labeling, and EEG. The company offers consultancy, data acquisition, data analysis, and development services, leveraging cloud computing and machine learning to deliver rapid, scalable, and comprehensive neuroimaging insights. Based in London, L&M Data Science targets pharmaceutical companies seeking to enhance translational value in CNS drug development and early clinical trial success.